Is the Interruption of Antiretroviral Treatment During Pregnancy an Additional Major Risk Factor for Mother‐to‐Child Transmission of HIV Type 1?
Author(s) -
Luisa Galli,
Donella Puliti,
Elena Chiappini,
Clara Gabiano,
G. Ferraris,
F Mig,
M Viganò,
Carlo Giaquinto,
Orazio Genovese,
Gianfranco Anzidei,
Raffaele Badolato,
Wilma Buffolano,
Anna Maccabruni,
Filippo Salvini,
Monica Cellini,
Maurizio Ruggeri,
Mariano Manzionna,
Stefania Bernardi,
PierAngelo Tovo,
Maurizio de Martino
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/597774
Subject(s) - medicine , interquartile range , pregnancy , odds ratio , confidence interval , viral load , prospective cohort study , cohort , obstetrics , cohort study , logistic regression , confounding , gestation , pediatrics , human immunodeficiency virus (hiv) , surgery , immunology , genetics , biology
There is currently an experts' agreement discouraging interruption of antiretroviral treatment (ART) during the first trimester of pregnancy in women infected with human immunodeficiency virus type 1 (HIV-1). However, this recommendation is poorly supported by data. We evaluated the effects of discontinuing ART during pregnancy on the rate of mother-to-child transmission.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom